Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Ardian targets €5bn for new private credit fund
French alternative asset manager Ardian is looking to raise at least €5bn (£4.3bn) for its sixth private credit fund. The Paris-headquartered firm’s private credit division, headed up by Mark Brenke, typically provides senior debt facilities to mid-sized companies. It...
Carlyle launches sale of Japanese cosmetics supplier Tokiwa in $800 million deal
Private equity firm Carlyle Group has begun the sale process of Japanese cosmetics supplier Tokiwa Corp in a deal that could value the company at $800 million. Non-binding bids for the company are expected by mid-March, said the sources, who declined to be named as...
EQT wraps up Future Fund at $3.3bn
Private equity investor, EQT has held the final close of its EQT Future fund at €3bn (US$ 3.3bn) in total commitments, with total fee-generating commitments for the overall strategy, including co-investments, totalling €3.6bn. It comes one week after EQT closed its...